Skip to main content

Table 1 Summary of patient demographics and clinicopathological characteristics

From: Protein expression profiles and clinicopathologic characteristics associate with gastric cancer survival

Clinicopathological characteristics

Patients N = 121 (%)

Age (years)

 ≤ 60

57 (47.1)

 > 60

64 (52.9)

Gender

 Male

91 (75.2)

 Female

30 (24.8)

Tumor location

 Lower third

85 (70.2)

 Middle third

23 (19.0)

 Upper third

13 (10.8)

Tumor size (cm)a

 ≤ 5

94 (77.7)

 > 5

27 (22.3)

Histologic differentiation

 Moderate

38 (31.4)

 Poor

83 (68.6)

Vascular/lymphatic invasion

 Absent

37 (30.6)

 Present

84 (69.4)

T stage

 T1

7 (5.8)

 T2

29 (24.0)

 T3

84 (69.4)

 T4

1 (0.8)

N stage

 N0

35 (29.0)

 N1

45 (37.1)

 N2

29 (24.0)

 N3

12 (9.9)

TNM stageb

 I

19 (15.7)

 II

27 (22.4)

 III

62 (51.2)

 IV

13 (10.7)

  1. aTumor size measured in greatest transverse diameter (cm)
  2. bTNM staging was performed according to the American Joint Committee on Cancer. No patient had metastasis to distant organs (M0)